about
Veraxa Biotech Holding AG focus on antibody therapies in medicine. The Company is an oncology-focused biotechnology Company with a clinical program in acute myeloid leukemia and two proprietary platform technologies that enable the development of new...
Read More
2.12
-0.06
(-2.75%)
81,359.0
XNAS Volume
XNAS 20 Jul, 2026 12:39 PM (EDT)
Not Eligible
Expensive Valuation
No Score Avaliable
Veraxa Biotech AG Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..